Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
FreenomeFRNM +0.84%8 OCF Margin % is -363.94% as of Dec. 2025. GuruFocus rates FRNM with a GF Score™ of 8/100. Among 204 Medical Diagnostics & Research companies, Freenome ranks worse than 89.22% on this metric.
The historical rank and industry rank for Freenome's OCF Margin % or its related term are showing as below:
FRNM'
s OCF Margin % Range Over the Past 10 Years
Min: 0 Med: 0 Max: 0
Current: -363.94
FRNM's OCF Margin % is ranked worse than 89.22% of 204
companies
in the Medical Diagnostics & Research industry
Industry Median: 4.755
vs FRNM: -363.94
Freenome OCF Margin % Related Terms
Freenome OCF Margin % Historical Data
* Premium members only.
The historical data trend for Freenome's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Freenome OCF Margin % Chart
Freenome Annual Data
Trend
Dec24
Dec25
OCF Margin %
-6,813.57
-363.94
Freenome Semi-Annual Data
Dec24
Dec25
OCF Margin %
-6,813.57
-363.94
FRNM vs : OCF Margin % Comparison
For the Diagnostics & Research subindustry, Freenome's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Freenome OCF Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Freenome's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Freenome's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Freenome (FRNM) has a OCF Margin % of -363.94% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Freenome and its competitors. According to the industry distribution chart, Freenome ranks #182 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 89.2%.
Is Freenome's OCF Margin % too high?
Freenome's current OCF Margin % is -363.94%. Based on the distribution chart, Freenome ranks #182 out of 204 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Freenome has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Freenome's OCF Margin % compare to ?
According to the Medical Diagnostics & Research industry distribution chart, Freenome ranks #182 out of 204 companies for OCF Margin %. This places Freenome in the lower half of its industry. The industry median OCF Margin % is 4.76. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Diagnostics & Research company?
The median OCF Margin % among Medical Diagnostics & Research companies is 4.76, based on 204 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Freenome and its competitors. For the Medical Diagnostics & Research industry, the median OCF Margin % is 4.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Freenome's current OCF Margin % is -363.94%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Freenome stock overvalued right now?
Freenome (FRNM) has a current OCF Margin % of -363.94%. The current OCF Margin % is -363.94%. Freenome's overall GF Score™ is 8/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Freenome (FRNM), the current OCF Margin % is -363.94% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Freenome Inc is a development-stage, early cancer detection company developing blood-based screening tests leveraging a proprietary artificial intelligence/machine learning multiomics technology platform to transform multi-cancer and ultimately multi-disease detection. It is developing a range of blood-based cancer screening tests.
8GF Score
Get the complete analysis for FRNM
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRNM has been successfully added to your 
